Active ingredientLopinavirCat. No. P-L090-001CAS 192725-17-0Family · Pharmaceutical analytical standards
Lopinavir
An HIV protease inhibitor approved in 2000, available only in a fixed combination with a low dose of ritonavir: this blocks the CYP3A4 enzyme, which would otherwise clear lopinavir quickly, and greatly raises its blood levels. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was designed to improve on ritonavir by using X-rays to study how molecules fit into the virus's protease, with help from the Advanced Photon Source synchrotron at Argonne National Laboratory in the United States.
Go to the active ingredient →Active ingredientLopinavirCat. No. P-L090-001CAS 192725-17-0
Pharmacopoeial impurityLopinavir EP Impurity ACat. No. P-L090-002CAS 192726-05-9
Pharmacopoeial impurityLopinavir EP Impurity ECat. No. P-L090-003CAS 192725-49-8
Pharmacopoeial impurityLopinavir EP Impurity FCat. No. P-L090-004CAS 2726380-74-9
Pharmacopoeial impurityLopinavir EP Impurity GCat. No. P-L090-005CAS 3023702-69-1
Pharmacopoeial impurityLopinavir EP Impurity QCat. No. P-L090-006CAS 667904-94-1
Pharmacopoeial impurityLopinavir EP Impurity RCat. No. P-L090-007CAS 943250-66-6
Pharmacopoeial impurityLopinavir EP Impurity SCat. No. P-L090-008CAS 943250-65-5
Pharmacopoeial impurityLopinavir EP Impurity TCat. No. P-L090-009CAS 2942244-19-9
MetaboliteLopinavir Metabolite 1Cat. No. P-L090-010CAS 192725-39-6
MetaboliteLopinavir Metabolite 2 (Mixture of Diastereomers)Cat. No. P-L090-011CAS 357275-54-8
Isotopically labelledLopinavir-d8Cat. No. P-L090-012CAS 1224729-35-4
NitrosamineN-Nitroso Lopinavir EP Impurity ECat. No. P-L090-013
NitrosamineN-Nitroso Lopinavir EP Impurity LCat. No. P-L090-014
Impurity2-(2,6-Dimethylphenoxy)acetic AcidCat. No. P-L090-015CAS 13335-71-2
Impurity4-Oxo LopinavirCat. No. P-L090-016
ImpurityLopinavir Isoleucine AnalogueCat. No. P-L090-017CAS 1132765-59-3
Pharmacopoeial impurityLopinavir EP Impurity JCat. No. P-L090-018
ImpurityLopinavir Carboxymethyl AnalogueCat. No. P-L090-019CAS 1989516-33-7
Pharmacopoeial impurityLopinavir EP Impurity KCat. No. P-L090-020CAS 1623021-24-8
Pharmacopoeial impurityLopinavir EP Impurity PCat. No. P-L090-022CAS 1217628-64-2
Pharmacopoeial impurityLopinavir EP Impurity NCat. No. P-L090-023CAS 1798014-18-2
ImpurityLopinavir Impurity 1Cat. No. P-L090-024
Pharmacopoeial impurityLopinavir EP Impurity DCat. No. P-L090-025
ImpurityLopinavir Impurity 3Cat. No. P-L090-026CAS 1370045-08-1
ImpurityLopinavir Leucine AnalogueCat. No. P-L090-027CAS 1132765-60-6
ImpurityLopinavir Impurity 5Cat. No. P-L090-028
ImpurityLopinavir Impurity 6Cat. No. P-L090-029
ImpurityLopinavir Impurity 7 (Mixture of Diastereomers)Cat. No. P-L090-030
ImpurityLopinavir Impurity 8Cat. No. P-L090-031
ImpurityLopinavir Impurity 9Cat. No. P-L090-032CAS 1177745-08-2
Impurity(2S)-3-Methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanoic AcidCat. No. P-L090-034CAS 192725-50-1
Pharmacopoeial impurityLopinavir EP Impurity BCat. No. P-L090-035
Pharmacopoeial impurityLopinavir EP Impurity OCat. No. P-L090-036
Pharmacopoeial impurityLopinavir EP Impurity HCat. No. P-L090-037
ImpurityLopinavir Trifluoroacetamide ImpurityCat. No. P-L090-038CAS 2125942-48-3
Pharmacopoeial impurityLopinavir EP Impurity LCat. No. P-L090-039
ImpurityRitonavir Hydroxypropyl Carbamate AnalogCat. No. P-L090-040CAS 1010809-50-3No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceLopinavir CRSEDQM code Y0001498Family LopinavirNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.